Phase 4 Study of Tapentadol vs Oxycodone in Neuropathic Pain.

Trial Profile

Phase 4 Study of Tapentadol vs Oxycodone in Neuropathic Pain.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 15 May 2014

At a glance

  • Drugs Tapentadol (Primary) ; Oxycodone
  • Indications Neuropathic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Mar 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 06 Jun 2012 Primary endpoint amended as reported by ClinicalTrials.gov.
    • 16 Nov 2011 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top